Examples of Aggressive Endometrial Cancer Limited to a Polyp or Endometrium
Aggressive endometrial cancers that can be limited to a polyp or confined to the endometrium include serous carcinoma, clear cell carcinoma, grade 3 endometrioid carcinoma, carcinosarcoma, undifferentiated carcinoma, mesonephric-like carcinoma, and gastrointestinal-type mucinous carcinoma.
Specific Aggressive Histotypes
According to the 2025 ESGO-ESTRO-ESP guidelines, aggressive histotypes are defined as 1:
- High-grade endometrioid carcinoma (grade 3)
- Serous carcinoma
- Clear cell carcinoma
- Carcinosarcoma
- Undifferentiated carcinoma
- Mixed carcinoma
- Mesonephric-like carcinoma
- Gastrointestinal-type mucinous carcinoma
The NCCN 2025 guidelines confirm this same categorization of aggressive histologies 2.
Clinical Presentations in Polyps
Serous Carcinoma
Serous carcinoma has a particularly strong association with endometrial polyps. Research demonstrates that more than two-thirds of minimal uterine serous carcinomas (MUSC) involve an endometrial polyp, and over 50% are confined entirely to a polyp at the time of staging hysterectomy 3. This suggests that most MUSCs arise within endometrial polyps. Despite being confined to a polyp or endometrium, serous carcinoma carries high risk for extrauterine spread 4.
Clear Cell Carcinoma
Clear cell carcinoma can present as disease confined to an atrophic endometrial polyp 5. This is an aggressive tumor type that typically exhibits poor differentiation and high-grade features, even when limited to the endometrium or polyp.
Gastrointestinal-Type Carcinoma
Gastric (gastrointestinal)-type endometrial adenocarcinoma can present as a solitary endometrial polyp 6. This is a rare but potentially aggressive histotype recently added to the WHO classification.
Critical Clinical Considerations
Molecular Classification is Essential
The 2025 guidelines emphasize that molecular classification is needed to properly allocate risk groups, particularly for aggressive histologies 1. Grade 3 endometrioid carcinomas and other aggressive histologies are molecularly heterogeneous, containing all four molecular subtypes (POLEmut, MMRd, NSMP, p53abn) with vastly different prognoses 2.
Prognosis Despite Limited Disease
Even when aggressive histologies are confined to a polyp or endometrium without myometrial invasion, they can still have poor outcomes. A multi-institutional study found that 14.5% of patients with serous carcinoma limited to the endometrium experienced recurrence, and extrauterine disease was present in some cases despite no myometrial invasion 4. However, another study showed that with proper surgical staging, 3-year progression-free survival was 91% for high-grade carcinomas limited to endometrium or polyp 7.
Staging Requirements
Complete surgical staging with total hysterectomy, bilateral salpingo-oophorectomy, and lymph node assessment is mandatory 1, 7. For serous carcinoma, carcinosarcoma, and undifferentiated carcinoma, infracolic omentectomy should be performed even in clinical stage I-II disease 1.
Common Pitfalls
- Do not assume benign behavior based solely on lack of myometrial invasion - aggressive histologies can metastasize even when confined to the endometrium or polyp
- Do not skip molecular classification - this is critical for accurate risk stratification and treatment planning in aggressive histologies
- Do not omit complete surgical staging - lymph node assessment and omentectomy (for specific histotypes) are essential even in apparent early disease